Programme

Session I: Personalized Diagnostics and Treatment   

Personalized breast cancer screening

Per Hall, Professor, Karolinska Institutet, Sweden

Does it pay off - cost-effectiveness in real world screening 

Nicolien van Ravesteyn, Assistant Professor, Erasmus MC, Rotterdam, Netherlands

Senomac Ultra

Helle Skjerven, Breast and Endocrine Surgeon, Oslo University Hospital, Oslo, Norway

The role of exercise in breast cancer survival

Nikolai Kragøe Andresen, MD, Oslo University Hospital, Oslo, Norway

TBA 

Session II: When is Enough Enough?

TILs in breast cancer: from biomarker to treatment de-escalation - manual versus AI-based assessment

Roberto Salgado, Pathologist, Institut Jules Bordet/TCRU GZA, Antwerp, Belgium

Overdiagnosis

Harald Weedon-Fekjær, Senior Researcher, Oslo University Hospital, Oslo, Norway

Consequences and results of implementing AI in Breast Cancer Screening in Capital Region in Denmark

Ilse Vejborg, Chief Physician/Head of Screening, Gentofte Hospital, Copenhagen, Denmark

When Less Becomes Too Little: Results from the DBCG Natural Trial

Birgitte Vrou Offersen, Professor, Aarhus University, Aarhus, Denmark

Localization of non-palpable breast cancer: which technique is the best one? (MELODY study)

Maggie Banys-Paluchowski, Professor, University Hospital Schleswig-Holstein, Lübeck, Germany

TBA

Session III: Artificial Intelligence

Artificial Intelligence in Breast Pathology: Current Clinical Impact and Future Directions 

Balazs Acs, Associate Professor, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden

AI in mammography: experiences from the AIMS studies

Solveig Hofvind, Researcher, Cancer Registry of Norway

SMART-journal: Supporting medical documentation with AI

Margareta Grøholt Kiær, Department of Research and Innovation, Vestre Viken HF, Drammen, Norway

TBA

Session IV: Tumor board and project presentations

Tumor board

Project presentations (4-6 presentations, 10 min each)

Closing remarks